About Neurona Therapeutics
Neurona Therapeutics is a private company based in South San Francisco, California. It has reported $347,475,339 raised in six offerings on Form D since December 2014.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | Apr 4, 2025 | $101,711,423fully sold | 46 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Feb 6, 2024 | Feb 13, 2024 | $119,999,974fully sold | 35 | $3.4M | EquityRule 506(b) | Form D ↗ |
| Mar 19, 2021 | Mar 29, 2021amended Dec 23, 2022 | $72,008,582of $91.5M target | 21 | $3.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 18, 2019 | Nov 25, 2019 | $15,030,288of $49.9M target | 9 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Feb 8, 2018 | Feb 27, 2018 | $10,044,329of $20.0M target | 6 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Dec 9, 2014 | Dec 23, 2014amended Dec 28, 2016 | $28,680,743of $30.3M target | 13 | $2.2M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, six offerings | $347,475,339 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Neurona Therapeutics's Form D filed Apr 4, 2025.
PS
TK
BM
Brad Margus
Director
CN
Cory Nicholas
Executive officer, director and promoter
JS
James Stutz
Chief Financial Officer
RK
Ray Kelleher
Director
EW
Erica Whittaker
Director
LG
Leo Guthart
Director
Earlier filings also listed Robert Tjian (director, last listed Feb 2024), Erica Whitaker (director, last listed Feb 2024), Stephen Hauser (director, last listed Dec 2022), Arnold Kriegstein (director, last listed Dec 2022), Robert Tijan (director, last listed Feb 2018) and David Goeddel (director, last listed Dec 2016).